Published in N Engl J Med on October 02, 1997
Proton Therapy for Lymph Nodes in Breast Cancer (BR01) | NCT01365845
Intensity Modulated Radiotherapy for Breast Cancer (IMRT) | NCT00594477
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA (2008) 5.25
Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med (2015) 4.94
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol (2012) 4.33
Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst (2005) 2.93
Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ (2000) 2.80
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys (2011) 2.54
Does tumour dormancy offer a therapeutic target? Nat Rev Cancer (2010) 2.19
Stopping metastases at their source. N Engl J Med (1997) 2.03
The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg (2004) 1.87
Complications After Mastectomy and Immediate Breast Reconstruction for Breast Cancer: A Claims-Based Analysis. Ann Surg (2016) 1.86
Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol (2009) 1.74
What Is the Optimum Timing of Postmastectomy Radiotherapy in Two-Stage Prosthetic Reconstruction: Radiation to the Tissue Expander or Permanent Implant? Plast Reconstr Surg (2015) 1.65
Why does specialist treatment of breast cancer improve survival? The role of surgical management. Br J Cancer (2004) 1.65
The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys (2014) 1.61
Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. CMAJ (2004) 1.51
Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network Guidelines. JAMA Oncol (2016) 1.48
Is there any argument for delayed breast reconstruction after total mastectomy? Ann R Coll Surg Engl (2007) 1.47
Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ (2004) 1.46
Male breast cancer: is the scenario changing. World J Surg Oncol (2008) 1.45
Breast cancer in young women and its impact on reproductive function. Hum Reprod Update (2009) 1.40
Postmastectomy Radiation Therapy and Two-Stage Implant-Based Breast Reconstruction: Is There a Better Time to Irradiate? Plast Reconstr Surg (2016) 1.40
New paradigms and future challenges in radiation oncology: an update of biological targets and technology. Sci Transl Med (2013) 1.35
Metaplastic breast cancer: to radiate or not to radiate? Ann Surg Oncol (2010) 1.33
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer. Clin Proteomics (2011) 1.32
Treatment options for metaplastic breast cancer. ISRN Oncol (2012) 1.30
Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women. J Med Genet (2005) 1.24
Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy. CMAJ (2001) 1.19
Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy. Radiother Oncol (2010) 1.19
Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer. Ann Surg (2004) 1.18
Clinico-pathological and treatment-related factors influencing survival in parotid cancer. Br J Cancer (1999) 1.17
Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys (2007) 1.17
Qigong improves quality of life in women undergoing radiotherapy for breast cancer: results of a randomized controlled trial. Cancer (2013) 1.14
Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer. Int J Radiat Oncol Biol Phys (2010) 1.13
Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer. J Clin Oncol (2010) 1.12
Effects of yoga on symptom management in breast cancer patients: A randomized controlled trial. Int J Yoga (2009) 1.11
Evaluation of skin dose associated with different frequencies of bolus applications in post-mastectomy three-dimensional conformal radiotherapy. J Exp Clin Cancer Res (2009) 1.11
Sentinel lymph node biopsy of the internal mammary chain in breast cancer. Breast Cancer Res Treat (2012) 1.10
Racial disparities in breast cancer survival: an analysis by age and stage. J Surg Res (2008) 1.09
Specialisation and breast cancer survival in the screening era. Br J Cancer (2003) 1.09
A systematic review of morbidity associated with autologous breast reconstruction before and after exposure to radiotherapy: are current practices ideal? Ann Surg Oncol (2014) 1.08
Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data. Int J Hyperthermia (2010) 1.08
Management of axillary lymph nodes in breast cancer: a national patterns of care study of 17,151 patients. Ann Surg (1999) 1.05
Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Ann Surg (2003) 1.04
Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth? Cancers (Basel) (2010) 1.04
Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke. Br J Cancer (2009) 1.03
Triple-negative breast cancer is not a contraindication for breast conservation. Ann Surg Oncol (2011) 1.03
Validation of a radiosensitivity molecular signature in breast cancer. Clin Cancer Res (2012) 1.02
Letrozole sensitizes breast cancer cells to ionizing radiation. Breast Cancer Res (2004) 1.01
Abnormalities by pulmonary regions studied with computer tomography and clinical correlation following local-regional radiotherapy for breast cancer. South Asian J Cancer (2013) 1.00
Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients. World J Surg (2007) 1.00
Optimization of dose distribution with multi-leaf collimator using field-in-field technique for parallel opposing tangential beams of breast cancers. J Med Phys (2008) 0.98
Breast reconstruction with tissue expanders and implants: a practical guide to immediate and delayed reconstruction. Semin Plast Surg (2004) 0.98
Reduction of radiation pneumonitis by V20-constraints in breast cancer. Radiat Oncol (2010) 0.97
Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg (2003) 0.97
The role of radiotherapy in management of pancreatic cancer. J Gastrointest Oncol (2011) 0.97
Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors. Genome Biol (2013) 0.97
Wide tangential fields including the internal mammary lymph nodes in patients with left-sided breast cancer. Influence of respiratory-controlled radiotherapy (4D-CT) on cardiac exposure. Strahlenther Onkol (2009) 0.96
Post mastectomy linac IMRT irradiation of chest wall and regional nodes: dosimetry data and acute toxicities. Radiat Oncol (2013) 0.96
Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer? Br J Cancer (1999) 0.95
Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: is there a role for radiation therapy? Radiat Oncol (2011) 0.95
Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network. Int J Radiat Oncol Biol Phys (2008) 0.95
Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer (2004) 0.94
Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes. Ann Surg Oncol (2014) 0.94
Non-compliance with a postmastectomy radiotherapy guideline: decision tree and cause analysis. BMC Med Inform Decis Mak (2008) 0.94
NSABP breast cancer clinical trials: recent results and future directions. Clin Med Res (2003) 0.94
Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes. Br J Cancer (2013) 0.94
Self-assembling doxorubicin silk hydrogels for the focal treatment of primary breast cancer. Adv Funct Mater (2013) 0.93
Future vision for the quality assurance of oncology clinical trials. Front Oncol (2013) 0.93
Doxorubicin-loaded silk films: drug-silk interactions and in vivo performance in human orthotopic breast cancer. Biomaterials (2012) 0.93
Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy. Ann Surg Oncol (2010) 0.92
Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy. Int J Clin Oncol (2011) 0.92
Intraoperative radiotherapy in the treatment of breast cancer: a review of the evidence. Int J Breast Cancer (2011) 0.92
Late Toxicity of Radiotherapy: A Problem or a Challenge for the Radiation Oncologist? Breast Care (Basel) (2011) 0.92
Radiotherapy and chemotherapy in high-risk breast cancer. N Engl J Med (1998) 0.91
Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process. Cancer (2009) 0.91
Postmastectomy radiation therapy: an overview for the practicing surgeon. ISRN Surg (2013) 0.91
Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy. Radiat Oncol (2013) 0.90
Breast reconstruction and post-mastectomy radiation practice. Radiat Oncol (2013) 0.90
Breast cancer multifocality and multicentricity and locoregional recurrence. Oncologist (2013) 0.90
Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys (2011) 0.89
Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis. Radiol Oncol (2014) 0.88
Breast conserving treatment for breast cancer: dosimetric comparison of different non-invasive techniques for additional boost delivery. Radiat Oncol (2014) 0.88
New trends in breast cancer management: is the era of immediate breast reconstruction changing? Ann Surg (2006) 0.88
Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study. BMC Cancer (2012) 0.87
Which patients might benefit from postmastectomy radiotherapy in breast cancer patients with t1-2 tumor and 1-3 axillary lymph nodes metastasis? Cancer Res Treat (2013) 0.87
Muscle-sparing TRAM flap does not protect breast reconstruction from postmastectomy radiation damage compared with the DIEP flap. Plast Reconstr Surg (2014) 0.87
Breast cancer in young women: special considerations in multidisciplinary care. J Multidiscip Healthc (2014) 0.87
Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients. World J Surg Oncol (2010) 0.86
Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer. Int J Radiat Oncol Biol Phys (2007) 0.86
Platelet gel in cutaneous radiation dermatitis. Support Care Cancer (2012) 0.86
Recent advances in the surgical care of breast cancer patients. World J Surg Oncol (2010) 0.86
Low locoregional recurrence rates in patients treated after 2000 with doxorubicin based chemotherapy, modified radical mastectomy, and post-mastectomy radiation. Radiother Oncol (2010) 0.86
Radiation impact in breast cancer. Breast Cancer Res (2009) 0.86
Recent advances in breast cancer radiotherapy: Evolution or revolution, or how to decrease cardiac toxicity? World J Radiol (2010) 0.86
Radiotherapy can improve the disease-free survival rate in triple-negative breast cancer patients with T1-T2 disease and one to three positive lymph nodes after mastectomy. Oncologist (2013) 0.86
Adjuvant irradiation for breast cancer. BMJ (2000) 0.85
Evaluation of the radiotherapy treatment planning in the presence of a magnetic valve tissue expander. PLoS One (2015) 0.85
Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes. J Breast Cancer (2016) 0.85
Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery. J Am Coll Surg (2013) 0.85
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet (1999) 8.44
RNA polymerase IV directs silencing of endogenous DNA. Science (2005) 6.66
Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27
An interspersed repeated sequence specific for human subtelomeric regions. EMBO J (1990) 5.30
Risk factors for anastomotic leakage after anterior resection of the rectum. Colorectal Dis (2004) 4.02
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69
Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol (1996) 3.59
Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell (1985) 3.59
Juvenile Rheumatism in London. Ann Rheum Dis (1939) 3.56
Trial of a trial by media. Med J Aust (2002) 3.11
Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now! Int J Radiat Oncol Biol Phys (1995) 3.05
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ (2000) 2.80
Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci U S A (1989) 2.59
Steepness of the dose-response curve as a function of volume in an experimental tumor irradiated under ambient or hypoxic conditions. Int J Radiat Oncol Biol Phys (1997) 2.48
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet (1996) 2.41
Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2-years-old: conclusions and recommendations of the Technical Consultation. Public Health Nutr (2007) 2.34
Preoperative PET/CT in early-stage breast cancer. Ann Oncol (2012) 2.33
Type I collagen synthesis and degradation in peritendinous tissue after exercise determined by microdialysis in humans. J Physiol (1999) 2.32
Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn's disease. Aliment Pharmacol Ther (2012) 2.29
Patient's and doctor's delay in primary breast cancer. Prognostic implications. Acta Oncol (1994) 2.27
Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev (1990) 2.24
[Improved prognosis of breast cancer]. Ugeskr Laeger (1994) 2.21
Human brain atlas: For high-resolution functional and anatomical mapping. Hum Brain Mapp (1994) 2.20
Load-displacement properties of the human triceps surae aponeurosis and tendon in runners and non-runners. Scand J Med Sci Sports (2002) 2.11
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol) (2007) 2.07
Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn's disease. Aliment Pharmacol Ther (2012) 2.07
[Cholesterol reduction: ischemic heart disease and mortality from non-ischemic heart diseases]. Ugeskr Laeger (1994) 2.06
HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol (2000) 2.05
QT dispersion in patients with arrhythmogenic right ventricular dysplasia. Eur Heart J (1999) 2.04
[Frequent occurrence of malnutrition at Swedish hospitals. Increased risk of complications and prolonged length of stay]. Lakartidningen (1994) 2.03
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci (2002) 2.01
Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure. Scand J Med Sci Sports (2010) 1.97
Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr (1992) 1.93
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res (1993) 1.86
Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study. J Clin Oncol (1994) 1.79
Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol Scand (1995) 1.79
Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut (2008) 1.75
Incidence of thyroid cancer in New Caledonia, South Pacific, during 1985-1992. Am J Epidemiol (1995) 1.74
The effect of supervised rehabilitation on strength, postural sway, position sense and re-injury risk after acute ankle ligament sprain. Scand J Med Sci Sports (1999) 1.72
Eccentric rehabilitation exercise increases peritendinous type I collagen synthesis in humans with Achilles tendinosis. Scand J Med Sci Sports (2006) 1.70
The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat (1994) 1.69
Timing of postexercise protein intake is important for muscle hypertrophy with resistance training in elderly humans. J Physiol (2001) 1.69
Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med (2001) 1.68
Epstein-Barr virus DNA in human lymphoid cell lines: in vitro conversion. Virology (1976) 1.67
Prognosis after head injury based on early clinical examination. Lancet (1973) 1.67
Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer (2003) 1.66
Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla. Eur J Surg Oncol (1988) 1.65
Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med (2001) 1.65
Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest (1999) 1.64
Clonal success of piliated penicillin nonsusceptible pneumococci. Proc Natl Acad Sci U S A (2007) 1.64
Fine structural and growth characteristics of cultured rat liver cells. Insulin effects. Exp Cell Res (1972) 1.63
The natural history of prostate carcinoma based on a Danish population treated with no intent to cure. Cancer (1997) 1.63
Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med (1999) 1.63
Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J (2001) 1.61
A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol (2000) 1.61
Enforced mobilization, early oral feeding, and balanced analgesia improve convalescence after colorectal surgery. Nutrition (2002) 1.60
Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease. Scand J Med Sci Sports (2001) 1.60
Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer. J Clin Oncol (1987) 1.59
The prognostic relevance of estimates of proliferative activity in early breast cancer. Histopathology (2003) 1.58
Differential strain patterns of the human gastrocnemius aponeurosis and free tendon, in vivo. Acta Physiol Scand (2003) 1.58
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival. Lancet (1996) 1.58
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. J Thromb Haemost (2003) 1.57
Load-displacement properties of the human triceps surae aponeurosis in vivo. J Physiol (2001) 1.56
Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. Int J Radiat Oncol Biol Phys (1980) 1.55
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial. Eur J Cancer (1999) 1.55
Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer (2001) 1.55
Cerebral ischaemic lesions and oral contraception. Dan Med Bull (1971) 1.54
Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst (2000) 1.54
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res (2003) 1.54
Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Eur J Cancer Clin Oncol (1987) 1.53
Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue. Eur J Clin Invest (1996) 1.53
Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Cancer Res (1987) 1.53
Germ-free and colonized mice generate the same products from enteric prodefensins. J Biol Chem (2000) 1.52
Human target validation of phosphoinositide 3-kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor. J Thromb Haemost (2012) 1.52
Airborne cell analysis. Anal Chem (2000) 1.51
Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma. Eur Respir J (2001) 1.50
Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency. Psychopharmacology (Berl) (1998) 1.50
High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics (1986) 1.49
Experimental exposure to wood smoke: effects on airway inflammation and oxidative stress. Occup Environ Med (2007) 1.49
Saposin fold revealed by the NMR structure of NK-lysin. Nat Struct Biol (1997) 1.49
Uveal and conjunctival malignant melanoma in Denmark, 1943-97: incidence and validation study. Ophthalmic Epidemiol (2005) 1.48
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res (1989) 1.48